170 related articles for article (PubMed ID: 8386948)
1. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men.
Stalsberg H; Thomas DB; Rosenblatt KA; Jimenez LM; McTiernan A; Stemhagen A; Thompson WD; Curnen MG; Satariano W; Austin DF
Cancer Causes Control; 1993 Mar; 4(2):143-51. PubMed ID: 8386948
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of different histologic types of breast cancer.
Li CI; Uribe DJ; Daling JR
Br J Cancer; 2005 Oct; 93(9):1046-52. PubMed ID: 16175185
[TBL] [Abstract][Full Text] [Related]
3. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
4. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
[TBL] [Abstract][Full Text] [Related]
5. Age distribution of histologic types of breast carcinoma.
Stalsberg H; Thomas DB
Int J Cancer; 1993 Apr; 54(1):1-7. PubMed ID: 8478135
[TBL] [Abstract][Full Text] [Related]
6. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
7. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.
Domagala W; Harezga B; Szadowska A; Markiewski M; Weber K; Osborn M
Am J Pathol; 1993 Mar; 142(3):669-74. PubMed ID: 8384406
[TBL] [Abstract][Full Text] [Related]
8. [Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases].
Hauser H; Beham A; Steindorfer P; Smola MG; Fruhwirth H; Klimpfinger M
Wien Klin Wochenschr; 1992; 104(23):717-20. PubMed ID: 1335634
[TBL] [Abstract][Full Text] [Related]
9. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.
Domagala W; Woźniak L; Lasota J; Weber K; Osborn M
Am J Pathol; 1990 Nov; 137(5):1059-64. PubMed ID: 2173410
[TBL] [Abstract][Full Text] [Related]
10. Histopathological features and their association with steroid receptors in women with breast cancer in Fukuoka, Japan.
Horie A; Nomura Y; Stemmermann GN; Catts A; Fukunaga FH; Shigematsu T; Hirohata T; Nomura AM
Acta Pathol Jpn; 1984 Mar; 34(2):229-39. PubMed ID: 6331061
[TBL] [Abstract][Full Text] [Related]
11. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
12. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
13. Pathologic predictors of recurrence in stage 1 (TINOMO) breast cancer.
Roses DF; Bell DA; Flotte TJ; Taylor R; Ratech H; Dubin N
Am J Clin Pathol; 1982 Dec; 78(6):817-20. PubMed ID: 6293299
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis.
Reiner A; Reiner G; Spona J; Schemper M; Holzner JH
Cancer; 1988 Mar; 61(6):1149-54. PubMed ID: 2830006
[TBL] [Abstract][Full Text] [Related]
15. Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma.
Erhardt K; Auer G; Folin A; Silfverswärd C; Skoog L
Am J Clin Oncol; 1986 Feb; 9(1):83-9. PubMed ID: 3006475
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.
Román M; Caicoya M; Espinàs J; Sala M; Torá-Rocamora I; Quinta MJ; Vernet M; Saladié F; Romero A; Sánchez M; Baré M; Vidal C; Servitja S; Natal C; Corominas J; Ferrer J; Rodríguez-Arana A; Castells X;
Breast J; 2018 Jul; 24(4):509-518. PubMed ID: 29517151
[TBL] [Abstract][Full Text] [Related]
17. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast cancer: histological subtypes and immunohistochemical and clinicopathological features.
Ishikawa Y; Horiguchi J; Toya H; Nakajima H; Hayashi M; Tagaya N; Takeyoshi I; Oyama T
Cancer Sci; 2011 Mar; 102(3):656-62. PubMed ID: 21214677
[TBL] [Abstract][Full Text] [Related]
19. Multicentricity and bilaterality in invasive breast carcinoma.
Lesser ML; Rosen PP; Kinne DW
Surgery; 1982 Feb; 91(2):234-40. PubMed ID: 6277027
[TBL] [Abstract][Full Text] [Related]
20. Breast carcinoma in women age 25 years or less.
Kothari AS; Beechey-Newman N; D'Arrigo C; Hanby AM; Ryder K; Hamed H; Fentiman IS
Cancer; 2002 Feb; 94(3):606-14. PubMed ID: 11857291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
